Rivastigmine
| CAS No. | 123441-03-2 | Cat. No. | BCP08735 |
| Name | Rivastigmine | ||
| Synonyms | Exelon;ENA713; ENA 713; ENA-713; SDZ-ENA 713; SDZ-ENA713; SDZ-ENA-713; | ||
| Formula | C14H22N2O2 | M. Wt | 250.34 |
| Description | Rivastigmine, also known as ENA-713, is a carbamate-derived reversible cholinesterase inhibitor that is selective for the central nervous system and is used for the treatment of Dementia, Alzheimer's Disease and Parkinson's Disease. It acts by covalently modifying a serine residue in the active site by carbamoylation, as it stabilizes or reduces the rate of decline in certain cognitive functions. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | AChE | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.